相关实验视频

Updated: May 16, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

7.8K

在"HER2-阴性"乳腺癌中HER2瘤表达率低或零:基于表型的长期结果

Israel Barco1, Clarisa González2, Marc García-Font3

  • 1Breast Unit Department of Gynecology, Research Foundation Mútua Terrassa/University of Barcelona/Hospital of Mútua Terrassa, Terrassa, Barcelona, Spain. ibarco@mutuaterrassa.es.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|April 4, 2025
PubMed
概括

HER2 0阳性乳腺癌 (BC) 的预后比HER2-低BC更糟糕,特别是在Luminal A亚型. 这种新的分类有助于理解BC差异.

关键词:
乳腺癌 乳腺癌 乳腺癌HER2 0 + HER2 0 + HER2 0 + HER2 0 + HER2 0 + HER2 0 + HER2 0 + HER2在HER2的低水平下,免疫组织化学瘤亚型的确定死亡率 死亡率 死亡率幸存的生存方式

更多相关视频

Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer11:47

Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer

Published on: February 8, 2013

11.8K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

5.9K

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
311